Clinical Trial Update: Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. [Phase 3]

View source ↗

Summary

Phase 3 trial update for BG2109 evaluating efficacy and safety in heavy menstrual bleeding associated with uterine fibroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• BG2109

Snippet

Sponsor: Bio Genuine (Shanghai) Biotech Co., Ltd. | Conditions: Uterine Fibroids, Heavy Menstrual Bleeding | Phase 3 | Status: UNKNOWN